[1] WLODZIMIROW KA,ESLAMI S,ABU-HANNA A,et al. A systematic review on prognostic indicators of acute on chronic liver failure and their predictive value for mortality[J]. Liver Int,2013,33(1):40-52.
|
[2] Chinese Society of Infectious Diseases Liver Failure and Artificial Liver Group,Hepatology Branch of Chinese Medical Association Severe Liver Disease and Artificial Liver Group. Guidelines for diagnosis and treatment of liver failure B:A2018 edition[J]. J Clin Hepatol,2019,37(1):1-9.(in Chinese)中华医学会感染病学分会肝衰竭与人工肝学组,中华医学会肝病学分会重型肝病与人工肝学组.肝衰竭诊治指南(2018年版)[J].临床肝胆病杂志,2019,37(1):1-9.
|
[3] BERNAL W,JALAN R,QUAGLIA A,et al. Acute-on-chronic liver failure[J]. Lancet(London,England),2015,386(10003):1576-1587.
|
[4] ARROYO V,MOREAU R,JALAN R,et al. Acute-on-chronic liver failure:A new syndrome that will re-classify cirrhosis[J]. J Hepatol,2015,62(1 Suppl):s131-s143.
|
[5] KATOONIZADEH A,LALEMAN W,VERSLYPE C,et al. Early features of acute-on-chronic alcoholic liver failure:A prospective cohort study[J]. Gut,2010,59(11):1561-1569.
|
[6] DING R,ZHAO H,YAN J,et al. Defination and treatment progress of acute-on-chronic liver failure[J/CD]. Chin J Liver Dis(Electronic Version),2018,10(1):1-5.(in Chinese)丁蕊,赵红,闫杰,等.慢加急性肝衰竭的定义及治疗进展[J/CD].中国肝脏病杂志(电子版),2018,10(1):1-5.
|
[7] SARIN S K,KEDARISETTY CK,ABBAS Z,et al. Acute-onchronic liver failure:Consensus recommendations of the Asian Pacific Association for the Study of the Liver(APASL)2014[J]. Hepatol Int,2014,8(4):453-471.
|
[8] TRIANTAFYLLOU E,WOOLLARD KJ,MCPHAIL MJW,et al.The role of monocytes and macrophages in acute and acuteon-chronic liver failure[J]. Front Immunol,2018,9:2948.
|
[9] ZHANG DJ,ZHOU B,HOU JL. Research progress in prognostic models of acute-on-chronic liver failure[J]. J Clin Hepatol,2018,34(6):1351-1356.(in Chinese)张东敬,周彬,侯金林.慢加急性肝衰竭预后模型的研究进展[J].临床肝胆病杂志,2018,34(6):1351-1356.
|
[10] SIMONETTO DA,PICCOLO SERAFIM L,GALLO DE MORAES A,et al. Management of sepsis in patients with cirrhosis:Current evidence and practical approach[J]. Hepatology,2019,70(1):418-428.
|
[11] BERNARDI M,MOREAU R,ANGELI P,et al. Mechanisms of decompensation and organ failure in cirrhosis:From peripheral arterial vasodilation to systemic inflammation hypothesis[J]. J Hepatol,2015,63(5):1272-1284.
|
[12] SARIN SK,CHOUDHURY A. Acute-on-chronic liver failure:Terminology,mechanisms and management[J]. Nat Rev Gastroenterol Hepatol,2016,13(3):131-149.
|
[13] WANG C,MA DQ,LUO S,et al. Incidence of infectious complications is associated with a high mortality in patients with hepatitis B virus-related acute-on-chronic liver failure[J].World J Clin Cases,2019,7(16):2204-2216.
|
[14] XIE G J,ZHANG H Y,CHEN Q,et al. Changing etiologies and outcome of liver failure in Southwest China[J]. Virol J,2016,13:89.
|
[15] CLARIA J,STAUBER RE,COENRAAD MJ,et al. Systemic inflammation in decompensated cirrhosis:Characterization and role in acute-on-chronic liver failure[J]. Hepatology,2016,64(4):1249-1264.
|
[16] SOLE C,SOLA E,MORALES-RUIZ M,et al. Characterization of inflammatory response in acute-on-chronic liver failure and relationship with prognosis[J]. Sci Rep,2016,6:32341.
|
[17] MIKOLASEVIC I,MILIC S,RADIC M,et al. Clinical profile,natural history, and predictors of mortality in patients with acute-on-chronic liver failure(ACLF)[J]. Wien Klin Wochenschr,2015,127(7-8):283-289.
|
[18] LEI CJ,WU LP. Clinical types and biochemical indexes in patients with drug-induced liver failure[J/CD]. Chin J Liver Dis(Electronic Version),2018,10(1):70-73.(in Chinese)雷创杰,吴柳萍.药物性肝衰竭患者的临床分型及生物化学指标的差异[J/CD].中国肝脏病杂志(电子版),2018,10(1):70-73.
|